{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:53:41Z","timestamp":1778882021459,"version":"3.51.4"},"reference-count":77,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"6","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2019,12,12]]},"DOI":"10.1167\/tvst.8.6.28","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T16:31:00Z","timestamp":1576168260000},"page":"28","source":"Crossref","is-referenced-by-count":3,"title":["Systematic Screening, Rational Development, and Initial Optimization of Efficacious RNA Silencing Agents for Human Rod Opsin Therapeutics"],"prefix":"10.1167","volume":"8","author":[{"given":"Edwin H.","family":"Yau","sequence":"first","affiliation":[{"name":"Department of Pharmacology\/Toxicology, University at Buffalo-SUNY, Buffalo, NY, USA"},{"name":"Department of Ophthalmology (Ross Eye Institute), University at Buffalo-SUNY, Buffalo, NY, USA"},{"name":"Current affiliation: Department of Medicine, Department of Cancer Genetics and Genomics, Roswell Park Cancer Institute, Buffalo, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert T.","family":"Taggart","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology (Ross Eye Institute), University at Buffalo-SUNY, Buffalo, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Zuber","sequence":"additional","affiliation":[{"name":"Research Service, VA Western New York Healthcare System, Buffalo, NY, USA"},{"name":"Current affiliation: Biologist, Office of Pesticide Programs, Environmental Protection Agency, Arlington, VA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandria J.","family":"Trujillo","sequence":"additional","affiliation":[{"name":"Department of Pharmacology\/Toxicology, University at Buffalo-SUNY, Buffalo, NY, USA"},{"name":"Department of Ophthalmology (Ross Eye Institute), University at Buffalo-SUNY, Buffalo, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra S.","family":"Fayazi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology (Ross Eye Institute), University at Buffalo-SUNY, Buffalo, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.","family":"Butler","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology (Ross Eye Institute), University at Buffalo-SUNY, Buffalo, NY, USA"},{"name":"Research Service, VA Western New York Healthcare System, Buffalo, NY, USA"},{"name":"Current affiliation: Custom ColLABorators, Buffalo, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lowell G.","family":"Sheflin","sequence":"additional","affiliation":[{"name":"Department of Pharmacology\/Toxicology, University at Buffalo-SUNY, Buffalo, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer B.","family":"Breen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology (Ross Eye Institute), University at Buffalo-SUNY, Buffalo, NY, USA"},{"name":"Current affiliation: Research Analyst II, Athenex, Buffalo, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dian","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology (Ross Eye Institute), University at Buffalo-SUNY, Buffalo, NY, USA"},{"name":"Current affiliation: Washington National Eye Center, Medstar Georgetown University Hospital\/Medstar Washington Hospital, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack M.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology\/Toxicology, University at Buffalo-SUNY, Buffalo, NY, USA"},{"name":"Department of Ophthalmology (Ross Eye Institute), University at Buffalo-SUNY, Buffalo, NY, USA"},{"name":"Research Service, VA Western New York Healthcare System, Buffalo, NY, USA"},{"name":"Department of Physiology\/Biophysics, University at Buffalo-SUNY, Buffalo, NY, USA"},{"name":"Neuroscience Program, University at Buffalo-SUNY, Buffalo, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27","reference":[{"key":"i2164-2591-8-6-28-b01","doi-asserted-by":"crossref","unstructured":"Millington-Ward S, O'Neill B, Tuohy G, et al. Strategems in vitro for gene therapies directed to dominant mutations. Hum Mol Genet. 1997; 6: 1415\u20131426.","DOI":"10.1093\/hmg\/6.9.1415"},{"key":"i2164-2591-8-6-28-b02","unstructured":"Sullivan JM, Pietras KM, Shin BJ, Misasi JN. Hammerhead ribozymes designed to cleave all human rod opsin mRNAs which cause autosomal dominant retinitis pigmentosa. Mol Vis. 2002; 8: 102\u2013113."},{"key":"i2164-2591-8-6-28-b03","doi-asserted-by":"crossref","unstructured":"Cashman SM, Binkley EA, Kumar-Singh R. Towards mutation-independent silencing of genes involved in retinal degeneration by RNA interference. Gene Ther. 2005; 12: 1223\u20131228.","DOI":"10.1038\/sj.gt.3302512"},{"key":"i2164-2591-8-6-28-b04","doi-asserted-by":"crossref","unstructured":"O'Reilly M, Palfi A, Chadderton N, et al. RNA interference-mediated suppression and replacement of human rhodopsin in vivo. Am J Hum Genet. 2007; 81: 127\u2013135.","DOI":"10.1086\/519025"},{"key":"i2164-2591-8-6-28-b05","doi-asserted-by":"crossref","unstructured":"O'Reilly M, Millington-Ward S, Palfi A, et al. A transgenic mouse model for gene therapy of rhodopsin-linked retinitis pigmentosa. Vision Res. 2008; 48: 386\u2013391.","DOI":"10.1016\/j.visres.2007.08.014"},{"key":"i2164-2591-8-6-28-b06","doi-asserted-by":"crossref","unstructured":"Gorbatyuk M, Justilien V, Liu J, Hauswirth WW, Lewin AS. Preservation of photoreceptor morphology and function in P23H rates using an allele independent ribozyme. Exp Eye Res. 2007; 84: 44\u201352.","DOI":"10.1016\/j.exer.2006.08.014"},{"key":"i2164-2591-8-6-28-b07","doi-asserted-by":"crossref","unstructured":"Kiang AS, Palfi A, Ader M, et al. Toward a gene therapy for dominant disease: validation of an RNA interference-based mutation-independent approach. Mol Ther. 2005; 12: 555\u2013561.","DOI":"10.1016\/j.ymthe.2005.03.028"},{"key":"i2164-2591-8-6-28-b08","doi-asserted-by":"crossref","unstructured":"Palfi A, Ader M, Kiang AS, et al. RNAi-based suppression and replacement of rds-peripherin in retinal organotypic culture. Hum Mutat. 2006; 27: 260\u2013268.","DOI":"10.1002\/humu.20287"},{"key":"i2164-2591-8-6-28-b09","doi-asserted-by":"crossref","unstructured":"Sullivan JM, Yau EH, Kolniak TA, Sheflin LG, Taggart RT, and Abdelmaksoud H. Variables and strategies in development of therapeutic post-transcriptional gene silencing agents. J Ophthalmol. 2011; 2011: 531380.","DOI":"10.1155\/2011\/531380"},{"key":"i2164-2591-8-6-28-b10","doi-asserted-by":"crossref","unstructured":"Lieber A, Strauss M. Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library. Mol Cell Biol. 1995; 15: 540\u2013551.","DOI":"10.1128\/MCB.15.1.540"},{"key":"i2164-2591-8-6-28-b11","doi-asserted-by":"crossref","unstructured":"Scherr M, Rossi JJ. Rapid determination and quantitation of the accessibility to native RNAs by antisense oligodeoxynucleotides in murine cell extracts. Nucleic Acids Res. 1998; 26: 2455\u20132461.","DOI":"10.1093\/nar\/26.22.5079"},{"key":"i2164-2591-8-6-28-b12","doi-asserted-by":"crossref","unstructured":"Kretschmer-Kazemi F, Sczakiel, G. The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides. Nucleic Acids Res. 2003; 31: 4417\u20134424.","DOI":"10.1093\/nar\/gkg649"},{"key":"i2164-2591-8-6-28-b13","doi-asserted-by":"crossref","unstructured":"Brown K, Chu C, Rana T. Target accessibility dictates the potency of human RISC. Nat Struct Mol Biol. 2005; 12: 469\u2013470.","DOI":"10.1038\/nsmb931"},{"key":"i2164-2591-8-6-28-b14","doi-asserted-by":"crossref","unstructured":"Sullivan JM, Yau EH, Taggart RT, Butler MC, Kolniak TA. Bottlenecks in development of retinal therapeutic post-transcriptional gene silencing agents. Vision Res. 2008; 48: 453\u2013469.","DOI":"10.1016\/j.visres.2007.09.011"},{"key":"i2164-2591-8-6-28-b15","doi-asserted-by":"crossref","unstructured":"Sullivan JM, Yau EH, Taggart RT, Butler MC, Kolniak TA. Relieving bottlenecks in RNA drug discovery for retinal diseases. Adv Exp Med Biol. 2012; 723: 145\u2013153.","DOI":"10.1007\/978-1-4614-0631-0_20"},{"key":"i2164-2591-8-6-28-b16","doi-asserted-by":"crossref","unstructured":"Abdelmaksoud HE, Yau EH, Zuker M, Sullivan JM. Development of lead hammerhead ribozyme candidates against human rod opsin mRNA for retinal degeneration therapy. Exp Eye Res. 2009; 88: 859\u2013879.","DOI":"10.1016\/j.exer.2008.11.018"},{"key":"i2164-2591-8-6-28-b17","doi-asserted-by":"crossref","unstructured":"Yau EH, Butler MC, Sullivan JM. A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targets. Exp Eye Res. 2016; 151: 236\u2013255.","DOI":"10.1016\/j.exer.2016.05.020"},{"key":"i2164-2591-8-6-28-b18","doi-asserted-by":"crossref","unstructured":"Amarzguioui M, Prydz H. Hammerhead ribozyme design and application. Cell Mol Life Sci. 1998; 54: 1175\u20131202.","DOI":"10.1007\/s000180050247"},{"key":"i2164-2591-8-6-28-b19","doi-asserted-by":"crossref","unstructured":"Birikh KR, Heaton PA, Eckstein F. The structure, function and application of the hammerhead ribozyme. Eur J Biochem. 1997; 245: 1\u201316.","DOI":"10.1111\/j.1432-1033.1997.t01-3-00001.x"},{"key":"i2164-2591-8-6-28-b20","doi-asserted-by":"crossref","unstructured":"Uhlenbeck OC. A small catalytic oligoribonucleotide. Nature. 1987; 328: 596\u2013600.","DOI":"10.1038\/328596a0"},{"key":"i2164-2591-8-6-28-b21","doi-asserted-by":"crossref","unstructured":"Haseloff J, Gerlach WL. Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature. 1988; 334: 585\u2013591.","DOI":"10.1038\/334585a0"},{"key":"i2164-2591-8-6-28-b22","doi-asserted-by":"crossref","unstructured":"Hannon GJ. Interference. RNA Nature. 2002; 418: 244\u2013251.","DOI":"10.1038\/418244a"},{"key":"i2164-2591-8-6-28-b23","doi-asserted-by":"crossref","unstructured":"Caplen NJ, Parrish S, Imani F, Fire A, Morgan RA. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci U S A. 2001; 98: 9742\u20139747.","DOI":"10.1073\/pnas.171251798"},{"key":"i2164-2591-8-6-28-b24","doi-asserted-by":"crossref","unstructured":"Caplen NJ. RNAi as a gene therapy approach. Expert Opin Biol Ther. 2003; 3: 575\u2013586.","DOI":"10.1517\/14712598.3.4.575"},{"key":"i2164-2591-8-6-28-b25","doi-asserted-by":"crossref","unstructured":"Sullivan LS, Bowne SJ, Birch DG, et al. Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families. Invest Ophthalmol Vis Sci. 2006; 47: 3052\u20133064.","DOI":"10.1167\/iovs.05-1443"},{"key":"i2164-2591-8-6-28-b26","doi-asserted-by":"crossref","unstructured":"Sullivan LS, Bowne SJ, Reeves MJ, et al. Prevalence of mutations in eyeGENE probands with a diagnosis of autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2013; 54: 6255\u20136261.","DOI":"10.1167\/iovs.13-12605"},{"key":"i2164-2591-8-6-28-b27","doi-asserted-by":"crossref","unstructured":"Daiger SP, Bowne SJ, Sullivan LS. Genes and mutations causing autosomal dominant retinitis pigmentosa. Cold Spring Harb Perspect Med. 2015, 5: a017129.","DOI":"10.1101\/cshperspect.a017129"},{"key":"i2164-2591-8-6-28-b28","unstructured":"Froebel BF, Trujillo AJ, Sullivan JM. Effects of pathogenic variations in the human rhodopsin gene (hRHO) on the predicted accessibility for a lead candidate ribozyme. Invest Ophthalmol Vis Sci. 2017; 58: 3576\u20133591."},{"key":"i2164-2591-8-6-28-b29","doi-asserted-by":"crossref","unstructured":"Nathans J, Hogness DS. Isolation and nucleotide sequence of the gene encoding human rhodopsin. Proc Natl Acad Sci U S A. 1984; 81: 4851\u20134855.","DOI":"10.1073\/pnas.81.15.4851"},{"key":"i2164-2591-8-6-28-b30","doi-asserted-by":"crossref","unstructured":"Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003; 31: 3406\u20133415.","DOI":"10.1093\/nar\/gkg595"},{"key":"i2164-2591-8-6-28-b31","doi-asserted-by":"crossref","unstructured":"Ding Y, Chan C, Lawrence C. Sfold web server for statistical folding and rational design of nucleic acids. Nucleic Acids Res. 2004; 32: W135\u2013W141.","DOI":"10.1093\/nar\/gkh449"},{"key":"i2164-2591-8-6-28-b32","doi-asserted-by":"crossref","unstructured":"Mathews DH, Burkard ME, Freier SM, Wyatt JR, Turner DH. Predicting oligonucleotide affinity to nucleic acid targets. RNA. 1999; 5: 1458\u20131469.","DOI":"10.1017\/S1355838299991148"},{"key":"i2164-2591-8-6-28-b33","doi-asserted-by":"crossref","unstructured":"Popenda, M., Szachniuk, M., Antczak, et al. Automated 3D structure composition for large RNAs. Nucleic Acids Res. 2012; 40: e112.","DOI":"10.1093\/nar\/gks339"},{"key":"i2164-2591-8-6-28-b34","doi-asserted-by":"crossref","unstructured":"Zhang HY, Mao J, Zhou D, et al. mRNA accessible site tagging (MAST): a novel high throughput method for selecting effective antisense oligonucleotides. Nucleic Acids Res. 2003; 31: e72.","DOI":"10.1093\/nar\/gng072"},{"key":"i2164-2591-8-6-28-b35","unstructured":"Prislei S, Buonomo SM, Michienzi A, Bozzoni I. Use of adenoviral VAI small RNA as a carrier for cytoplasmic delivery of ribozymes. RNA. 1997; 3 677\u2013687."},{"key":"i2164-2591-8-6-28-b36","doi-asserted-by":"crossref","unstructured":"Brummelkamp TR., Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 2002; 296: 550\u2013553.","DOI":"10.1126\/science.1068999"},{"key":"i2164-2591-8-6-28-b37","doi-asserted-by":"crossref","unstructured":"Nathans J, Weitz CJ, Agarwal N, Nir I, Papermaster DS. Production of bovine rhodopsin by mammalian cell lines expressing cloned cDNA: spectrophotometry and subcellular localization. Vision Res. 1989; 29: 907\u2013914.","DOI":"10.1016\/0042-6989(89)90105-3"},{"key":"i2164-2591-8-6-28-b38","doi-asserted-by":"crossref","unstructured":"Stillman BW, Gluzman Y. Replication and supercoiling of Simian virus 40 DNA in cell extracts from human cells. Mol Cell Biol 1985; 5: 2051\u20132060.","DOI":"10.1128\/MCB.5.8.2051"},{"key":"i2164-2591-8-6-28-b39","doi-asserted-by":"crossref","unstructured":"Berger J, Hauber J, Hauber R, Geiger R, Cullen B. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene. 1988; 66: 1\u201310.","DOI":"10.1016\/0378-1119(88)90219-3"},{"key":"i2164-2591-8-6-28-b40","doi-asserted-by":"crossref","unstructured":"Fallaux FJ, Kranenburg D, Cramer SJ, et al. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther. 1996; 7: 215\u2013222.","DOI":"10.1089\/hum.1996.7.2-215"},{"key":"i2164-2591-8-6-28-b41","doi-asserted-by":"crossref","unstructured":"Ruffner DE, Stormo GD, Uhlenbeck OC. Sequence requirements of the hammerhead RNA self-cleavage reaction. Biochemistry. 1990; 29: 10595\u201310702.","DOI":"10.1021\/bi00499a018"},{"key":"i2164-2591-8-6-28-b42","doi-asserted-by":"crossref","unstructured":"Shimayama T, Nishikawa S, Taira K . Generality of the NUX rule: kinetic analysis of the results of systematic mutations in the trinucleotide at the cleavage site of hammerhead ribozymes. Biochemistry. 1995; 34: 3649\u20133654.","DOI":"10.1021\/bi00011a020"},{"key":"i2164-2591-8-6-28-b43","doi-asserted-by":"crossref","unstructured":"Zoumadakis M, Tabler M. Comparative analysis of cleavage rates after systematic permutation of the NUX? consensus target motif for hammerhead ribozymes. Nucleic Acids Res. 1995; 23: 1192\u20131196.","DOI":"10.1093\/nar\/23.7.1192"},{"key":"i2164-2591-8-6-28-b44","doi-asserted-by":"crossref","unstructured":"Homann M, Tabler M, Tzortzakaki S, Sczakiel G. Extension of helix II of an HIV-1 directed hammerhead ribozyme with long antisense flanks does not alter kinetic parameters in vitro but causes loss of the inhibitory potential in living cells. Nucleic Acids Res. 1994; 22: 3951\u20133957.","DOI":"10.1093\/nar\/22.19.3951"},{"key":"i2164-2591-8-6-28-b45","doi-asserted-by":"crossref","unstructured":"Hertel KJ, Herschlag D, Uhlenbeck OC. A kinetic and thermodynamic framework for the hammerhead ribozyme reaction. Biochemistry. 1994; 33: 3374\u20133385.","DOI":"10.1021\/bi00177a031"},{"key":"i2164-2591-8-6-28-b46","doi-asserted-by":"crossref","unstructured":"Long DM, Uhlenbeck OC. Kinetic characterization of intramolecular and intermolecular hammerhead RNAs with stem II deletions. Proc Natl Acad Sci U S A. 1994; 91: 6977\u20136981.","DOI":"10.1073\/pnas.91.15.6977"},{"key":"i2164-2591-8-6-28-b47","doi-asserted-by":"crossref","unstructured":"Haseloff J, Gerlach WL. Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature. 1988; 334 (6183): 585\u2013591.","DOI":"10.1038\/334585a0"},{"key":"i2164-2591-8-6-28-b48","doi-asserted-by":"crossref","unstructured":"Persson T, Hartmann RK, Eckstein F. Selection of hammerhead ribozyme variants with low Mg2+ requirement: importance of stem-loop II. Chembiochem. 2002; 3: 1066\u20131071.","DOI":"10.1002\/1439-7633(20021104)3:11<1066::AID-CBIC1066>3.0.CO;2-G"},{"key":"i2164-2591-8-6-28-b49","doi-asserted-by":"crossref","unstructured":"Khvorova A, Lescoute A, Westhof E, Jayasena SD. Sequence elements outside the hammerhead ribozyme catalytic core enable intracellular activity. Nat Struct Biol. 2003; 10: 708\u2013712.","DOI":"10.1038\/nsb959"},{"key":"i2164-2591-8-6-28-b50","doi-asserted-by":"crossref","unstructured":"Penedo JC, Wilson TJ, Jayasena SD, Khvorova A, Lilley DM. Folding of the natural hammerhead ribozyme is enhanced by interaction of auxiliary elements. RNA. 2004; 10: 880\u2013888.","DOI":"10.1261\/rna.5268404"},{"key":"i2164-2591-8-6-28-b51","doi-asserted-by":"crossref","unstructured":"Canny MD, Jucker FM, Kellogg E, Khvorova A, Jayasena SD, Pardi A. Fast cleavage kinetics of a natural hammerhead ribozyme. J Am Chem Soc. 2004; 126: 10848\u201310849.","DOI":"10.1021\/ja046848v"},{"key":"i2164-2591-8-6-28-b52","doi-asserted-by":"crossref","unstructured":"Lilley DM. Ribozymes\u2014a snip too far? Nat Struct Biol. 2003; 10: 672\u2013673.","DOI":"10.1038\/nsb0903-672"},{"key":"i2164-2591-8-6-28-b53","doi-asserted-by":"crossref","unstructured":"Carbonell A, Flores R, Gago S. Trans-cleaving hammerhead ribozymes with tertiary stabilizing motifs: in vitro and in vivo activity against a structured viroid RNA. Nucleic Acids Res. 2010; 39: 2432\u20132444.","DOI":"10.1093\/nar\/gkq1051"},{"key":"i2164-2591-8-6-28-b54","doi-asserted-by":"crossref","unstructured":"Scott WG, Horan LH, Martick M. The hammerhead ribozyme: structure, catalysis and gene regulation. Prog Mol Biol Transl Sci. 2013; 120: 1\u201323.","DOI":"10.1016\/B978-0-12-381286-5.00001-9"},{"key":"i2164-2591-8-6-28-b55","doi-asserted-by":"crossref","unstructured":"De la Pena M, Flores R. An extra nucleotide in the consensus catalytic core of a viroid hammerhead ribozyme: implications for the design of more efficient ribozymes. J Biol Chem. 2001; 276: 34586\u201334593.","DOI":"10.1074\/jbc.M103867200"},{"key":"i2164-2591-8-6-28-b56","doi-asserted-by":"crossref","unstructured":"Dufour D, de la Pena M, Gago S, Flores R, Gallego J. Structure-function analysis of the ribozymes of chrysanthemum chlorotic mottle viroid: a loop-loop interaction motif conserved in most natural hammerhead. Nucleic Acids Res. 2009; 37: 368\u2013381.","DOI":"10.1093\/nar\/gkn918"},{"key":"i2164-2591-8-6-28-b57","unstructured":"Shaw LC, Skold A, Wong F, Petters R, Hauswirth WW, Lewin AS. An allele-specific hammerhead ribozyme gene therapy for a porcine model of autosomal dominant retinitis pigmentosa. Mol Vis. 2001; 7: 6\u201313."},{"key":"i2164-2591-8-6-28-b58","doi-asserted-by":"crossref","unstructured":"Cideciyan AV, Sudharsan R, Dufour VK, et al. Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector. Proc Natl Acad Sci U S A. 2018; 115: E8547\u2013E8556.","DOI":"10.1073\/pnas.1805055115"},{"key":"i2164-2591-8-6-28-b59","doi-asserted-by":"crossref","unstructured":"Rosenfeld PJ, Cowley GS, McGee TL, Sandberg MA, Berson EL, Dryja TP. A null mutation in the rhodopsin gene causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosa. Nat Genet. 1992; 1: 209\u2013213.","DOI":"10.1038\/ng0692-209"},{"key":"i2164-2591-8-6-28-b60","doi-asserted-by":"crossref","unstructured":"McInnes RR, Bascom RA. Retinal genetics: a nullifying effect for rhodopsin. Nat Genet. 1992; 1: 155\u2013157.","DOI":"10.1038\/ng0692-155"},{"key":"i2164-2591-8-6-28-b61","doi-asserted-by":"crossref","unstructured":"Humphries MM, Rancourt D, Farrar GJ, et al. Retinopathy induced in mice by targeted disruption of the rhodopsin gene. Nat Genet. 1997; 15: 216\u2013219.","DOI":"10.1038\/ng0297-216"},{"key":"i2164-2591-8-6-28-b62","doi-asserted-by":"crossref","unstructured":"Lem J, Krasnoperova NV, Calvert PD, et al. Morphological, physiological, and biochemical changes in rhodopsin knockout mice. Proc Natl Acad Sci U S A. 1999; 96: 736\u2013741.","DOI":"10.1073\/pnas.96.2.736"},{"key":"i2164-2591-8-6-28-b63","unstructured":"Tan E, Wang Q, Quiamao AB, et al. The relationship between opsin overexpression and photoreceptor degeneration. Invest Ophthalmol Vis Sci. 2001; 42: 589\u2013600."},{"key":"i2164-2591-8-6-28-b64","unstructured":"Frederick JM, Krasnoperova NV, Hoffmann K, et al. Mutant rhodopsin transgene expression on a null background. Invest Ophthalmol Vis Sci. 2001; 42: 826\u2013833."},{"key":"i2164-2591-8-6-28-b65","doi-asserted-by":"crossref","unstructured":"Wen XH, Shen L, Brush RS, et al. Overexpression of rhodopsin alters the structure and photoresponse of rod photoreceptors. Biophys J. 2009; 96 (3): 939\u2013950.","DOI":"10.1016\/j.bpj.2008.10.016"},{"key":"i2164-2591-8-6-28-b66","doi-asserted-by":"crossref","unstructured":"Deigan KE, Li TW, Mathews DH, Weeks KM. Accurate SHAPE-directed RNA structure determination. Proc Natl Acad Sci U S A. 2009; 106: 97\u2013102.","DOI":"10.1073\/pnas.0806929106"},{"key":"i2164-2591-8-6-28-b67","doi-asserted-by":"crossref","unstructured":"Du Q, Thonberg H, Wang J, Wahlestedt C, Liang Z. A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites. Nucleic Acids Res. 2005; 33: 1671\u20131677.","DOI":"10.1093\/nar\/gki312"},{"key":"i2164-2591-8-6-28-b68","doi-asserted-by":"crossref","unstructured":"Jackson AL, Burchard J, Schelter J, et al. Widespread siRNA \u201coff-target\u201d transcript silencing mediated by seed region sequence complementarity. RNA. 2006; 12: 1179\u20131187.","DOI":"10.1261\/rna.25706"},{"key":"i2164-2591-8-6-28-b69","doi-asserted-by":"crossref","unstructured":"Dua P, Yoo JW, Kim S, Lee DK. Modified siRNA structure with a single nucleotide bulge overcomes conventional siRNA-mediated off-target silencing. Mol Ther. 2011; 19: 1676\u20131687.","DOI":"10.1038\/mt.2011.109"},{"key":"i2164-2591-8-6-28-b70","doi-asserted-by":"crossref","unstructured":"Kamola PJ, Nakano Y, Takahashi T, Wilson PA, Ui-Tei K. The siRNA non-seed region and its target sequences are auxiliary determinants of off-target effects. PLoS Comput Biol. 2015; 11: e1004656.","DOI":"10.1371\/journal.pcbi.1004656"},{"key":"i2164-2591-8-6-28-b71","doi-asserted-by":"crossref","unstructured":"Seok H, Lee H, Jang ES, Chi SW. Evaluation and control of miRNA-like off-target repression for RNA interference. Cell Mol Life Sci. 2018; 75: 797\u2013814.","DOI":"10.1007\/s00018-017-2656-0"},{"key":"i2164-2591-8-6-28-b72","doi-asserted-by":"crossref","unstructured":"Bertrand E, Pictet R, Grange T. Can hammerhead ribozymes be efficient tools to inactivate gene function? Nucleic Acids Res. 1994; 22: 293\u2013300.","DOI":"10.1093\/nar\/22.3.293"},{"key":"i2164-2591-8-6-28-b73","doi-asserted-by":"crossref","unstructured":"Emilsson GM, Nakamura S, Roth A, Breaker RR. Ribozyme speed limits. RNA. 2003; 9: 907\u2013918.","DOI":"10.1261\/rna.5680603"},{"key":"i2164-2591-8-6-28-b74","doi-asserted-by":"crossref","unstructured":"Breaker RR, Emilsson GM, Lazarev D, et al. A common speed limit for RNA-cleaving ribozymes and deoxyribozymes. RNA. 2003; 9: 949\u2013957.","DOI":"10.1261\/rna.5670703"},{"key":"i2164-2591-8-6-28-b75","doi-asserted-by":"crossref","unstructured":"Nelson JA, Uhlenbeck OC. Minimal and extended hammerheads utilize a similar dynamic reaction mechanism for catalysis. RNA. 2008; 14: 43\u201354.","DOI":"10.1261\/rna.717908"},{"key":"i2164-2591-8-6-28-b76","doi-asserted-by":"crossref","unstructured":"Shepotinovskaya IV, Uhlenbeck OC. Catalytic diversity of extended hammerhead ribozymes. Biochemistry. 2008; 47: 7034\u20137042.","DOI":"10.1021\/bi7025358"},{"key":"i2164-2591-8-6-28-b77","doi-asserted-by":"crossref","unstructured":"McDowell SE, Jun JM, Walter NG. Long-range tertiary interactions in single hammerhead ribozymes bias motional sampling toward catalytically active conformations. RNA 2010; 16: 2414\u20132426.","DOI":"10.1261\/rna.1829110"}],"container-title":["Translational Vision Science &amp; Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2757427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T09:56:55Z","timestamp":1665223015000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2757427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.8.6.28","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,12]]}}}